Cannovation Clinical Research Partners | Finanzwire

Basculer en Français

10820	Companies
234662	Keywords
163523	Articles
125584	Press releases

Headlines Articles Press releases Cannovation Clinical Research Partners

Home
Companies
Cannovation Clinical Research Partners

BRIEF

published on 05/08/2024 at 12:05, 2 years 3 months ago

Cannovation Clinical Research Partners Launches, Aiming to Revolutionize Cannabinoid-Based Therapeutics

Drug Development Biopharmaceutical Innovation Cannovation Clinical Research Cannabinoid-based Therapeutics Commercialization Strategies
PRESS RELEASE

published on 05/08/2024 at 12:00, 2 years 3 months ago

Introducing Cannovation Clinical Research Partners, LLC: Pioneering the Future of BioPharmaceutical Cannabinoid-Based Therapeutics
Cannovation Clinical Research Partners launches to pioneer cannabinoid research, development, and commercialization in pharmaceutical and biotech industries. Co-founded by Lisa Rich-Milan and Michael Zaccaria, the company aims to revolutionize medicine

Innovation Pharmaceutical Biotech Cannovation Clinical Research Partners Cannabinoid Research

Accesswire

Published on 08/12/2026 at 00:00, 7 hours 22 minutes ago

Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 7 hours 42 minutes ago

RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/11/2026 at 23:15, 8 hours 7 minutes ago

Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador
Published on 08/11/2026 at 23:00, 8 hours 22 minutes ago

Prospectiva Resources Ltd. Completes Qualifying Transaction
Published on 08/11/2026 at 22:55, 8 hours 27 minutes ago

NV Gold Announces Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 08/12/2026 at 07:10, 12 minutes ago

Deutsche Konsum Real Estate AG publishes quarterly statement for the first nine months of the 2025/2026 financial year
Published on 08/12/2026 at 07:00, 22 minutes ago

MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
Published on 08/12/2026 at 07:00, 22 minutes ago

SCHOTT Pharma with strong third quarter and on track for planned growth
Published on 08/12/2026 at 07:00, 22 minutes ago

TUI delivered resilient Q3 underlying EBIT of €234.6m (at CC), demonstrating the strength of its business despite geopolitical headwinds and one-offs, FY26 guidance reaffirmed
Published on 08/12/2026 at 07:00, 22 minutes ago

E.ON remains on track and continues to invest in the energy transition

Les Echos

Published on 08/10/2026 at 18:00, 1 day 13 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 17:45, 1 day 13 hours ago

Weekly share buyback
Published on 08/10/2026 at 11:53, 1 day 19 hours ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 1 day 19 hours ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 1 day 21 hours ago

Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE